Ajax-Loading

Abbott Laboratories - Financial Leverage Ratio

Abbott Laboratories's Fiscal Year is From January To December.

The item "Financial-Leverage-Ratio" stands at 1.67 as of 09/30/2025, the lowest value since 03/31/2024.

As of the end of Abbott Laboratories's third quarter, the item "Financial Leverage Ratio" stands at 1.67. This represents a decrease of -2.75 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -10.70 percent compared to the value the year prior.
The 1 year change in percent is -10.70.
The 3 year change in percent is -19.07.

The Serie's long term average value is 1.82. It's latest available value, on 09/30/2025, is 8.26 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +7.18%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -21.32%.

Financial Leverage Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoIntuitive Surgical Inc - Financial Leverage Ratio206,245,888,000.00
LogoEssilorLuxottica S. A. - Financial Leverage Ratio172,241,486,586.05
LogoDanaher Corporation - Financial Leverage Ratio162,006,663,168.00
LogoBoston Scientific Corp - Financial Leverage Ratio144,567,730,176.00
LogoStryker Corporation - Financial Leverage Ratio139,209,850,880.00